Rapid onset of CD8 + aggressive T-cell lymphoma during bexarotene therapy in a patient with Sézary syndrome [8]

Journal of the American Academy of Dermatology

Volumn 53, Issue 6, 2005, Pages 1093-1095

  Kreuter, Alexander ^a   Altmeyer, Peter ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BEXAROTENE; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; RETINOID X RECEPTOR; VINCRISTINE;

AGED; CASE REPORT; CLINICAL FEATURE; ERYTHRODERMA; HEART FAILURE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LETTER; MALE; PRIORITY JOURNAL; PUVA; SEZARY SYNDROME; SKIN BIOPSY; SKIN DEFECT; T CELL LYMPHOMA; T LYMPHOCYTE;

AGED; CD8-POSITIVE T-LYMPHOCYTES; HUMANS; LYMPHOMA, T-CELL; MALE; SEZARY SYNDROME; SKIN NEOPLASMS; TETRAHYDRONAPHTHALENES; TIME FACTORS;

EID: 27944432539     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2005.06.044     Document Type: Letter

References (4)

1. K.S. McGinnis, M. Shapiro, C.C. Vittorio, A.H. Rook, and J.M. Junkins-Hopkins Psoralen plus long-wave UV-A (PUVA) and bexarotene therapy: an effective and synergistic combined adjunct to therapy for patients with advanced cutaneous T-cell lymphoma Arch Dermatol 139 2003 771 775
2. E. Berti, D. Tomasini, M.H. Vermeer, C. Meijer, E. Alessi, and R. Willemze Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas Am J Pathol 155 1999 483 492
3. F. Singh, and M.G. Lebwohl Cutaneous T-cell lymphoma treatment using bexarotene and PUVA: a case series J Am Acad Dermatol 51 2004 570 573
4. S.A. Bouwhuis, M.D. Davis, R.A. el-Azhary, M.T. McEvoy, L.E. Gibson, and J.M. Knudsen Bexarotene treatment of late-stage mycosis fungoides and Sézary syndrome: development of extracutaneous lymphoma in 6 patients J Am Acad Dermatol 52 2005 991 996